Reva Medical snags ex-MDT’er Groves for CEO | Personnel Moves

August 25, 2015 By Fink Densford Leave a Comment

Reva Medical (ASX:RVA) said last week it picked up ex-Medtronic (NYSE:MDT) divisional veep Regina Groves as its new CEO.

Groves was vice president and GM of the atrial fibrillation solutions, cardiac rhythm and heart failure division at Medtronic. During her time there, she helped the company strategize a re-entry into the catheter-based atrial fibrillation ablation market, the San Diego, Calif.-based company said.

“I am delighted to be given the opportunity to lead Reva, especially at this critical time while we complete the clinical trial of Fantom and prepare for commercialization. I believe the experience I bring to Reva provides a great foundation to lead the business to its next stages. I look forward to working with the Board and management team to evaluate our strategies, including a possible Nasdaq listing, as we bring this product to market,” Graves said in a press release.

Reva had been on an active hunt for a new CEO to replace co-founder, chairman & CEO Robert Stockman since May, hoping to find someone with European and U.S. regulatory and commercialization experience. The company said they would keep Stockman on until the transition was complete, and he would continue as board chairman.

“I am very excited and pleased to be transitioning the helm of REVA to someone as qualified as Reggie. She has proven leadership and commercialization skills that are an excellent fit for REVA’s growth and strategic plans,” Stockman said in prepared remarks.

EnteroMedix founder & CEO Knudson to retire
EnteroMedics (NSDQ:ETRM) said today its founder and current CEO Mark Knudson will retire at the end of 2015, but stay on as board chair. Board member Jon Tremmel will head the search for a new CEO, and serve as an advisor to the new chief during the transition.
Read more

Direct Flow lures MDT vet Edwards for regulatory & clinical veep
Direct Flow Medical said yesterday it hired ex-Medtronic Vascular regulatory affairs veep Mary Edwards to take over as its vice president of regulatory and clinical affairs, where she will oversee the administration of the pivotal trial of the company’s transcatheter aortic valve.
Read more

ReWalk Robotics founder, prez and CTO Goffer retiring
ReWalk Robotics (NSDQ:RWLK) said yesterday its founder, president and CTO Amit Goffer will retire, effective November 18. Goffer founded the company in 2001 and served as CEO through 2012, and has served as president and CTO since then.
Read more

DRG veep lands on Google advisory board
Healthcare analytics firm Decision Resources Group said last week its veep of digital innovation Monique Levy was picked to join Google’s (NSDQ:GOOG) healthcare advisory board, which was established in 2013 to help consumers make more informed healthcare decisions.
Read more

Mojo Vision developing ‘smart’ contact lens
Mojo Vision is working with the FDA to develop a smart contact lens to help people with low vision. The lens overlays real-time contrast and lighting enhancements with zoom functionality and recently won FDA breakthrough device designation. “Receiving the Breakthrough Device Designation is a significant step in our research and development process. We look forward to… […]
FDA to EPA: Leave us out of your ethylene oxide rule
This article has been updated with comments from the FDA. The FDA has asked the Environmental Protection Agency to leave the FDA out of its proposal for stricter regulation of ethylene oxide (EtO) emissions, and the EPA complied. In an interagency comment on the EPA’s proposed rule governing commercial EtO users — which includes medical… […]
Clippart debuts stepper-controlled flow valve
Clippard recently launched a new stepper-controlled proportional valve for precision flow control. The Eclipse valve uses the industry’s most robust and powerful miniature linear actuator, according to Cincinnati-based Clippard. The patent-pending Eclipse is designed for liquid and gas delivery, medical, analytical and industrial automation requiring ultra-fine resolution and repeatability. The design also allows for custom… […]
Supporting regulatory affairs departments to address clinical requirements under new MDR
By Dietmar Falke and Jaap Laufer, Emergo Group The May 25, 2020 MDR deadline is approaching rapidly, and by now many medical device manufacturers are aware that the MDR requires the proactive collection of post-marketing clinical follow-up (PMCF) data. Get the full story here at the Emergo Group’s blog. The opinions expressed in this blog… […]
5 tips to raise funding for your medical device
Securing funding can be a long and tedious process, and medical device businesses must work to position themselves as especially attractive to potential investors to maximize success and accelerate the fundraising process. Jon Speer, Greenlight Guru According to Alejandro Cremades, author of The Art of Startup Fundraising, it can take from six to nine months… […]
FDA recognizes latest ISO 14971 as medical device consensus standard
By Mark Leimbeck and Stewart Eisenhart, Emergo Group The US Food and Drug Administration has granted Recognized Consensus Standard status to the third edition of the ISO 14071 risk management standard for medical devices and IVD products. Get the full story here at the Emergo Group’s blog. The opinions expressed in this blog post are… […]
Synaptive Medical updates Modus V surgical microscope
Synaptive Medical announced that its U.S. and Canadian Modus V robotic digital microscope now includes updates such as additional 3D visualization and voice-activated control. The Modus V is a robotically controlled digital microscope used as part of Synaptive’s BrightMatter surgical suite designed for less invasive, patient-specific approaches in complex cranial procedures. The Modus V provides similar… […]
New machine can preserve donor livers for 1 week
Researchers in Switzerland have built a perfusion machine that can preserve human livers for transplantation for a week or more, potentially slashing the number of donor livers that must be discarded due to time-related deterioration. Existing perfusion technology can preserve a donor liver for up to 24 hours. The team of surgeons, biologists and engineers… […]
Smiths Medical launches Portex tracheostomy tubes and kits
Smiths Medical this week launched its Portex polyvinyl chloride tracheostomy tube and kit portfolio. The new polyvinyl chloride (PVC) tube portfolio has options for a variety of patients, according to the company. “Our goal was to create tracheostomy tubes and kits designed to help clinicians provide the best patient care. We’re excited to offer a variety… […]
FDA clears Cleveland Clinic 3D-printed airway stents
The FDA recently cleared 3D-printed, patient-specific stents developed by a doctor at the Cleveland Clinic. Cleveland Clinic physician Tom Gildea developed the stents to keep open the airways of patients with serious breathing disorders caused by inflammation, trauma, tumors and other masses. Airway stents come in a limited number of sizes and shapes and are… […]
Boston Scientific shares drop on Q4 sales news
Shares in Boston Scientific (NYSE:BSX) dropped 8% this morning on news of disappointing fourth-quarter sales. The company’s preliminary earnings report showed sales for the quarter ended Dec. 31, 2019 coming in at $2.9 billion, below the $2.91 billion that analysts were expecting. The unaudited sales figure represents organic growth of 7.3%, missing the company’s own guidance of… […]